Dachs Theresa-Marie, Hauck Sven Rudolf, Kern Maximilian, Klausenitz Catharina, Funovics Martin A
Abteilung für Kardiovaskuläre und Interventionelle Radiologie, Universitätsklinik für Radiologie und Nuklearmedizin, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich.
Institut für Radiologie, Klinik Floridsdorf, Wien, Österreich.
Radiologie (Heidelb). 2022 Jul;62(7):586-591. doi: 10.1007/s00117-022-01019-1. Epub 2022 Jun 20.
Today, complex abdominal aortic pathologies involving the visceral arteries and without an adequate proximal neck can be treated using fenestrated/branched endovascular aortic repair (FEVAR/BEVAR) with similar safety and success rates as infrarenal aortic pathologies treated with tubular EVAR.
Fenestrations (if the vessel originates from a nondilated aorta) or branches (if the vessel originates from a dilated aorta) may be used for the visceral arteries. Both types of openings are sealed via bridging stent grafts that connect to the target vessel. Multiple manufacturers offer fenestrated or branched endoprostheses, with only a few being CE certified and the majority in Europe being patient-specific custom-made devices. Therefore, they require a certain delivery time which precludes acute patients from such treatment. However, two stent grafts with four branches for thoracoabdominal aneurysms are available off the shelf and are anatomically suitable for the majority of patients, thus, allowing for acute treatment. All FEVAR and BEVAR main bodies require bridging stent grafts, all of which are used off-label.
As bridging stent grafts are one of the main reasons for reinterventions, one should be aware of fractures and kinking of the bridging stent grafts during follow-up and should refrain from using single-layered bridging stent grafts in BEVAR.
如今,涉及内脏动脉且近端颈部不充分的复杂腹主动脉病变,可采用开窗/分支型血管腔内主动脉修复术(FEVAR/BEVAR)进行治疗,其安全性和成功率与采用管状血管腔内主动脉修复术(EVAR)治疗的肾下腹主动脉病变相似。
对于内脏动脉,可采用开窗(如果血管起源于未扩张的主动脉)或分支(如果血管起源于扩张的主动脉)方式。这两种开口均通过连接到目标血管的桥接支架移植物进行密封。多个制造商提供开窗或分支型血管内假体,其中只有少数获得CE认证,在欧洲大多数是针对患者定制的设备。因此,它们需要一定的交付时间,这使得急性患者无法接受此类治疗。然而,有两种用于胸腹主动脉瘤的四分支支架移植物有现货,且在解剖学上适用于大多数患者,从而可进行急性治疗。所有FEVAR和BEVAR主体都需要桥接支架移植物,所有这些移植物均为超适应证使用。
由于桥接支架移植物是再次干预的主要原因之一,在随访期间应注意桥接支架移植物的骨折和扭结情况,并且在BEVAR中应避免使用单层桥接支架移植物。